This current study provided evidence of a connection between AK155(IL-26) and TLR9 rs5743836 in the COPD-tested cohort cases (Graphical Abstract), which paves the way for targeted immunotherapy alone or with immune-modulatory supplement(s) [58]. This evidence concerns the gene IL26 and chronic obstructive pulmonary disease.